Tyrosine kinase inhibitors in cancer therapy
Top Cited Papers
- 1 July 2004
- journal article
- review article
- Published by Elsevier in Clinical Biochemistry
- Vol. 37 (7) , 618-635
- https://doi.org/10.1016/j.clinbiochem.2004.05.006
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Suppression of ARG kinase activity by STI571 induces cell cycle arrest through up-regulation of CDK inhibitor p18/INK4cOncogene, 2003
- Erlotinib (Tarceva): An update on the clinical trial programSeminars in Oncology, 2003
- Mutational Analysis of the Tyrosine Kinome in Colorectal CancersScience, 2003
- Mechanism of action of erbB tyrosine kinase inhibitorsExperimental Cell Research, 2003
- Studies with ZD1839 in preclinical modelsSeminars in Oncology, 2003
- Pharmacology of imatinib (STI571)European Journal Of Cancer, 2002
- EGFR and cancer prognosisPublished by Elsevier ,2001
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Expression of hepatocyte growth factor and its receptor c- met proto-oncogene in hepatocellular carcinomaHepatology, 1997